Breast cancer genes pose threat to prostate health, too

Men whose mothers, daughters, or sisters have tested positive for the breast cancer genes BRCA1 and BRCA2 may want to find out if they carry the genes. Studies have shown that BRCA1 and BRCA2 carriers are more likely to develop prostate cancer than men without them. Now a British study suggests that these men are also more likely to suffer from more aggressive forms of the disease.

The researchers collected 20 tissue samples from men with the BRCA1 or BRCA2 genes and compared them with samples from patients with similar characteristics — age, prostate disease stage, and PSA level — but not the genes. Men with the genes had significantly higher Gleason scores than those in the control group. Higher Gleason scores are associated with more aggressive cancer and poorer outcome.

Targeted screening of male BRCA1 and BRCA2 carriers, the researchers say, could detect prostate disease at an earlier stage, possibly improving a patient's chances of a successful treatment.

SOURCE: Mitra A, Risher C, Foster CS, et al. Prostate Cancer in Male BRCA1 and BRCA2 Mutation Carriers Has a More Aggressive Phenotype. British Journal of Cancer 2008;98:502–507. PMID: 18182994.

Men's Health Watch
Published by Harvard Medical School, Harvard Men's Health Watch is a monthly newsletter that puts you in closer touch with everything that's happening now in cutting edge medicine – new prevention strategies, new medications, the latest diagnostic techniques and treatments. With men's health news spanning everything from prostate disease and nutrition and exercise, to erectile dysfunction and hair loss, Harvard Men's Health Watch delivers on its promise that "Knowledge is Power."

----------------------------------------------------------------------------------------

Click here to join the group Harvard Med: Talking About Health on Gather

You can find the following related articles on Gather:

What does a normal or negative screening test for cancer really mean?

Urine test accurately diagnoses prostate cancer

Gene combination raises prostate cancer risk